Elyse Greenspan

Binkley said PIF is relatively flat with Q2 as of now and, if the competitive direct environment persists, 2026 year-end PIF should be roughly flat year-over-year, modestly up from the ~482,000 at the end of 2025.

Binkley said underlying investment income on cash and fixed income was around $10 million; reported NII was $5 million after a full $4.4 million PE impairment, of which only ~$600,000 was original cash investment and $3.8 million reversed previously recognized unrealized gains. The PE portfolio is a small non-core position.

Timm said last year's model lifted customer LTVs by over 20%; the new model rolls out state-by-state starting in Q4, with limited impact this year but a stronger driver into next year.

Timm said mileage slightly down but discretionary miles being cut are low-frequency; frequency hasn't dropped much. Low single-digit trend environment. Cutting-edge claims models monitor daily; automated actuarial systems can take rate quickly if trend changes.

Timm said base case is competition stays hot or gets hotter as margins hold and rates decline. ROOT measures daily and can react quickly thanks to technology; not guessing, just measuring.

Binkley said repurchase authorization reflects strong excess capital position and confidence in long-term value. Will be opportunistic; continuing to invest in organic growth and technology alongside buybacks. New Huntington debt facility unlocks flexibility.

Timm acknowledged tax season was slightly more amplified this year; tariffs may have pulled up demand into Q1 via partnerships channel.

Binkley highlighted seasonal loss ratio pressure in Q2/Q3 toward 60-65% target. Declined to extrapolate quarterly results; will be opportunistic on marketing.

Timm said low-to-mid single-digit loss ratio impact expected; current below-target loss ratios provide buffer. Will take rate quickly if needed.

Timm deflected specific earnings guidance, emphasizing lifetime value framework. Warned some quarters may show P&L pressure from growth investment.

Timm expects slight loss ratio increases from rate decreases but nothing material, with low-to-mid single-digit loss trends.

Timm said no tariff impact predicted; tech platform enables real-time detection and rapid rate response, a competitive advantage.

Edmund clarified data center is a component of double-digit construction growth but emphasized Commercial Risk growth was broad-based at 7% with double-digit North America strength.

Edmund maintained at-least-$1B buyback target noting flexibility for M&A pipeline. Q1 $500M was opportunistic at prices below perceived intrinsic value.

Greg declined to size specific data center contribution, instead framing the opportunity as monumental and at the very beginning. Noted Aon likely does a third or more of current data center work. Edmund connected it to commercial risk's 6% full-year growth with construction at double digits. Both framed it as reinforcing mid-single-digit or greater growth rather than sizing it separately.

Edmund clarified no specific deal in progress but robust pipeline requiring strategic flexibility. Referenced Investor Day slide showing roughly 55-45 balance between inorganic investment and capital return. Greg reinforced capital discipline by citing NFP Wealth divestiture as proof point.

Edmund confirmed broad-based M&A growth across EMEA, Asia Pacific, and US. On margins, noted Commercial Risk has slightly higher margins but emphasized margin expansion driven by ABS operating leverage across both Risk Capital and Human Capital segments.

Edmund identified four drivers: operating income growth including NFP, working capital/DSO improvements, lower NFP transaction costs, and restructuring program. Greg emphasized ABS as a structural leverage mechanism for sustainable FCF growth beyond the 3x3 period.

Greg described it as a unique and very substantial program with huge value creation for the client. Edmund confirmed the timing impact won't carry into Q2 and pointed to strong second-half outlook from July 1 renewals and international facultative growth.

Edmund confirmed $2.8B 2024 base for double-digit FCF growth target. Noted Q1 is typically lowest FCF quarter, with integration/restructuring/incentive payments as seasonal factors. Core operating performance and DSO improvements will drive back-half growth.

Edmund directly confirmed that NFP's targeted tuck-in M&A EBITDA is fully embedded in the 2025 guidance across revenue, margin, and earnings.

Edmund acknowledged the trajectory but deferred specific 2026 capital allocation guidance, saying they will provide more detail closer to 2026.

Edmund dismissed seasonality concerns, noting only FX headwinds and fiduciary investment income as Q1 factors. Greg reinforced commitment to mid-single-digit+ growth.

Dan said yes over time, linking it to slower premium growth reducing the capital that must be retained to support growth.

Dan gave an unambiguous no and confirmed the uncertainty provision remains carried into 2026.

Michael Klein said gas prices need sustained elevation to meaningfully impact frequency through reduced miles driven. Called supply chain situation fast-moving with multiple scenarios, declining to speculate on a specific path.

Alan reiterated consistent M&A stance: actively evaluating all sizes of deals, looking for transactions that improve returns, lower volatility, or add strategic capability, but do not need any deal to succeed.

Michael said Q3 includes a small provision for tariff severity well below the mid-single-digit level previously forecast, with the situation fluid and Travelers continuing to monitor closely.

Dan declined to parse year-over-year detail on the BI underlying loss ratio but said Travelers really likes the margin level and the business being written at those margins.

Alan said OBB and Medicaid changes are not expected to meaningfully impact workers' comp, since workers' comp claimants are employed and, even if on Medicaid, usually default to WC as a better healthcare alternative.

Alan said the residual Canada capital isn't large enough to change Travelers' M&A view and will be reallocated to normal business and growth needs; no change to M&A strategy.

Michael reiterated that the tariff effect is a one-time severity step, not a trend change, and said any impact is more likely to show up in the back half of 2025 rather than Q2.

Dan said the wildfire cat losses will accumulate toward the $4B aggregate retention without triggering direct recoveries in Q1, but could set up recoveries later in 2025 if Q2 or Q3 turn out to be very active cat quarters.

Dan emphasized year-over-year (not sequential) comparison framework and said the Q4 underlying loss ratio is within a point of change with no abnormal items requiring adjustment from the clean jump-off point.

Doyle said digital infrastructure and transaction risk were important growth drivers in H1 and Q2, spanning insurance plus consulting and Mercer investments, with a robust pipeline going forward.

Doyle noted the decline reflected market consolidation plus pricing and urged against extrapolating the flat first half, citing casualty, M&A advisory, and alternative capital growth opportunities and a different second-half mix.

McGivney confirmed no change in strategy. Where M&A is light, will ramp up share repurchase as in Q4 ($1B) and Q1 ($750M). But AltamarCAM is a chunky deal expected to close later in year. Ultimate share repurchase depends on M&A pipeline development.

Doyle noted very soft property cat reinsurance market, particularly exposed in Q1 and Q2 with Japan and Florida. Client retention strong, excellent new business quarter. Not likely to be Guy Carpenter's best growth year. Has been planning and guiding for this.

Doyle deferred to January for 2026 guidance. Noted market conditions likely to persist. This year's mid-single-digit guidance was prudent despite initial criticism. Dynamic environment with much to settle.

Doyle clarified rebrand is about simplifying the story, showcasing breadth of capabilities, and building brand visibility. Years of alignment work in purpose, colleague value proposition, and strategy underpin the change.

Declined specific revenue disclosure. McGivney noted Q1 is smallest, Q2/Q4 are biggest, Q3 a smaller seasonal lull. Dilution trend from Q1 will moderate through the year.

Klisura confirmed property cat as growth headwind but balanced global growth. Record cat bonds ($1.8B, 8 deals). New capital advisory and boutique banking practice growing. H1 is 50% of annual GC revenue.

Doyle attributed Q4 margin pressure to FX and M&A mix effects. Emphasized 17 consecutive years of expansion and multiple levers ahead including AI and workflow optimization.

McGivney noted strong 28% FCF growth in 2023 made comps tough. Free cash flow doubled since 2019, expected to track earnings growth over time.

Q1 performance is key determinant for full year. Holiday slowdown typical. Hires up 15% (Liberty) and 17% (AIL) YoY are positive leading indicators. Expect 1-2 quarter lag between agent count growth and sales growth.

Organic growth preferred; buybacks remain baseline capital return. M&A considered if better return than buybacks and fits protection products/distribution strategy in lower-middle income market. Family Heritage acquisition cited as model.

No DOJ/SEC contact since start of 2025. No claims or allegations asserted. Company pursuing proactive resolution but agency timing is out of their control.

Centene issues are Medicaid/major medical, not applicable to GL's Medicare Supplement business. Different demographics and experience profiles.

Supplemental health margins stable. Return of premium product (Family Heritage) especially strong with good persistency and margins.

Generally ratable but will take advantage of market opportunities, potentially more front-loaded in H1.

No new details; update planned for next earnings call.

Buybacks will be roughly ratable with flexibility to pivot to M&A if opportunities arise. Company remains open to acquisitions expanding middle-income product offerings.

Management acknowledged utilization will outpace rate increases in 2025, expects to catch up over time but not immediately.

Quigg confirmed progress toward 3.5-to-1 for the vast majority of entities by end of 2026 and laid out the capital framework: reinvest first, then return excess via dividends and buybacks.

Griffith and Niederst framed growth as moderating from 2024-2025 peaks but still solid, detailing PIF growth by channel and reaffirming discipline of growing at or below a 96 combined ratio.

Griffith attributed premium per policy decline to mix changes from reopened underwriting aperture, emphasized PIF growth as the true long-term measure of growth.

Callahan highlighted unprecedented sustained shopping driven by affordability pressures, with longer-tenured shoppers entering market for first time in years. Investing while efficient.

Tricia said Progressive is not too worried about tariffs at this point given the margin cushion, though conditions could change.

Tricia highlighted the ~$230B Robinsons addressable market and the new business readiness growth framework targeting about 33 states (20 core growth, 13 volatile).

Tricia said growth is preferred, buybacks will continue to offset SBC dilution or when under intrinsic value, and the Board typically considers a variable dividend in December.

Tricia acknowledged comps get harder against 2024 but said the real opportunity is now growing Robinsons via the improved property book.

Tricia said Progressive has reached out to insurance departments and noted state-by-state decisions depend on both the combined ratio and growth momentum.

Management gave a constructive top-line read for July and said it does not see things falling off considerably from here.

Corrected assumption that growth slowed, January was actually the weakest month with improvement through the quarter. Clarified the growth-rate pivot is forward-looking.

Management expressed hope for Q2 improvement but couldn't commit to a timeline. Noted that quoting 60-90+ days out means the rate-to-growth pivot takes time to convert into written premium.

Berkley acknowledged market is more competitive overall but highlighted casualty pockets with attractive margins. Clarified that their bent toward casualty versus shorter-tail lines provides differentiated opportunities.

Rob said the primary and excess insurance book should grow faster than the Q4 total, while the reinsurance marketplace looks like history may be repeating itself and is becoming more challenging more quickly.

Rob said major parts of the market are in transition and WRB won't compromise rate integrity, framing underwriting discipline as a core obligation to shareholders.

Rob said the special dividend was the most efficient way to return capital in the quarter but WRB is not out of the repurchase market and evaluates the buyback tool every day.

Rich disclosed $11M unfavorable development in insurance offset by $12M favorable in reinsurance, and attributed the 30bp loss-ratio bump to business mix and outward reinsurance purchasing.

Rob deflected the segment reserve breakdown to post-call IR follow-up but flagged auto liability and umbrella/excess as the areas WRB is paying closest attention to.

Wilson characterized growth as balanced across channels and reframed the answer around customer segments and channel value propositions.

Wilson declined to commit to a normalization path, emphasizing adaptability and that current returns are highly attractive.

Wilson ranked priorities as organic growth first, M&A where Allstate is a better owner, then returning capital to shareholders via the new $4 billion buyback.

Wilson acknowledged the combined ratio would drift up over time as they grow fast and reduce prices, tying back to the $810 million affordability impact.

Wilson and Merten said inactive brand retention decline is intentional and moving customers to ASC products should improve retention over time.

Wilson said the $1.5B buyback program will finish in 2026, and capital priority is still organic growth in the Property-Liability business.

Wilson said shopping is elevated industry-wide from the rate cycle and used car prices have a slight uptick but attribution to tariff pull-forward is unclear.

Wilson said Allstate will raise prices if necessary, runs on thin margins, and expects home cost impact to be about half of the auto tariff magnitude, with tort reform as a partial offset.

Yanela declined to update targets or provide 2026 specifics. Reiterated non-linear growth trajectory and PGIM actions will drive operating efficiencies and growth. 3-year average target of 5-8% maintained.

Yanela confirmed June 30 ESR well above 150% target. Disclosure model will mirror PICA RBC: annual publication with interim qualitative updates relative to target. Quarterly ESR publication begins when JFSA requires it.

Yanela explained reconciling items flow both directions between net income and cash. Q2 difference roughly evenly split between items impacting and not impacting cash flows. No dividend taken from major domestic entities yet in 2025 but HoldCo cash strong. 65% free cash flow ratio is overtime measure.

Yanela reiterated growth not linear, 2025 likely below range average due to VA runoff and Japan surrender headwinds. As headwinds dissipate, growth will emerge more prominently. 5-8% is average over 3-year period.

Yanela clarified 65% of net income free cash flow target is an overtime measure, not quarterly. Q1 had strong $600M cash flows to holding company.

Yanela quantified VA runoff at $100-150M annual cumulative earnings impact from $3-4B quarterly runoff. Combined with $100M Japan surrender drag, both embedded in 5-8% target and expected to dissipate.

Rob confirmed ongoing balance sheet optimization, flow solutions, and third-party blocks across U.S. and Japan.

Yanela confirmed growth not linear, with 2025 being closer to near term with higher headwinds than out years, implying below-average growth.

Eric Andersen did not reaffirm a specific full-year figure, saying AIG is pleased with 13% first-half and 9% second-quarter growth, will not chase growth blindly, and will maintain underwriting discipline. He noted it is still early in the year and the team is pushing hard on available opportunities.

Keith Walsh noted AIG has not reiterated the 15-20% range in some time and currently sits at 17.6%, running conservative leverage with ample dry powder. He mentioned a Euro bond to be refinanced later in the year and said AIG is comfortable with its current leverage position.

Walsh confirmed $1B minimum repurchase plus Corebridge proceeds (vast majority to additional buybacks). Nippon Life waived 9.9% retention requirement enabling full sell-down in 2026.

Zaffino confirmed 2026 won't have the parent expense pushdown headwind, creating clean baseline. Expects meaningful improvement in 2026. Leverage from strong premium growth plus expense discipline. Not revising guidance but confident in sub-30% by 2027.

Zaffino said too premature to give July data but no concerning trends different from H1. Need to see how remaining two months play out before making any conclusions.

Zaffino declined to break down loss trends by line but confirmed casualty rate is covering loss cost trend. Noted property was removed from the index and stronger rate lines align with higher loss cost trend areas.

Max noted flat yield curve reduces urgency to deploy cash. Yen debt issuance has positive carry (230-235bp cost vs low 4% USD investment). Deployment will be IRR-driven.

Max expects Japan expense ratio in middle to lower end of 20-23% range despite continued technology projects, benefiting from cancer launch capitalization.

Max emphasized IRR-driven approach and organic growth as top priority, noted $750M was the most in a single quarter but wouldn't commit to a specific run rate.

Yoshizumi confirmed no impact on Aflac cancer insurance sales from Japan Post data issue and that Japan Post remains committed to selling Aflac products.

Ramy Tadros noted encouraging convergence between cedents and reinsurers on LTC deals but emphasized complexity and need for shareholder value maximization. Book is well capitalized, well reserved, performing in line. Talcott VA deal expected to close H2 with continued exploration of other risk transfers.

Ramy Tadros drew clear distinction between major medical and MetLife's voluntary fixed-dollar products. Critical illness running in line with expectations with no adverse cancer incidence. Warned against extrapolating medical trends into voluntary world.

John declined to break out MIM numbers before the formal segment reporting, now aiming to coincide with PineBridge closing in second half 2025.

John explained they use 12/31 forward curves, with LatAm peso weakness and yen in low 150s as primary FX headwinds in 2025.

Peter declined to disclose but back-pointed to ~2% ROE / ~6% ROTE historical drag implied by prior investor presentation math.